Apply to our Advance Biotech Grant Program and get a chance to benefit from products, services, and consultations from experts. Applications are open until April 30th, 2024.
With a process monitoring tunnel you can monitor 100s of CPPs in a single graphical interface that captures the overall health – both past and present – of your bioprocess and reliably predicts its future health.
Take a few minutes and navigate through our mAb, ADC, mRNA, Vaccine, and Cell and Gene Therapy process templates. Go ahead and dive into each unit operation to uncover the best option for your process.
If you’re a biotech company and part of a Bio-cluster organization, simply complete the form in this article to take a chance to win our latest cell counter scepter v3.0!
BioLabs builds innovation communities around Biotech entrepreneurs providing them with infrastructure, support, and networking to successfully succeed. Hear how BioLabs has launched 15 sites in the US, Europe and Asia with internationally known strategic partners.
Single-source manufacture of biopharmaceuticals is becoming more and more rare. Increasingly, biomanufacturers or “sponsor” companies partner with contract…
Insights on the changes in the biotech VC landscape and tips from an investor perspective for companies fundraising now.
Collaboration between biomanufacturers and CDMOs often experiences challenges with data sharing. This presentation highlights the management of heterogenous and asynchronous data and how a data integration platform can improve project lifecycle data management, and collaborative data sharing.
The definition of Good Laboratory Practice (GLP) is given by the Organization for Economic Co-operation and Development (OECD)…
Understanding regulatory expectations for ancillary/raw materials during development and early clinical phases can be challenging. Join in for a roadmap of current requirements, with a focus on Cell and Gene Therapies.
